Insiders Fled Tech. One Bet $15M Elsewhere.

Today's Top Insider Moves That Matter

Wall Street shrugged off caution today—but insiders didn’t. As tech ripped higher, consumer names surged, and industrials caught a strong bid, some of the sharpest minds in the C-suite started quietly selling. When stocks are green across the screen and insiders hit the sell button, it’s worth asking: what do they see that we don’t?

At the same time, buying wasn’t absent—it was precise. High-conviction purchases piled into overlooked names in housing, ag-tech, and regional banking. Cluster buys in struggling sectors suggest insiders aren’t chasing the rally—they’re positioning for what comes after.

The big takeaway? While the market celebrates risk, insiders are splitting—some cashing out at strength, others doubling down where fear still lingers.

Let’s decode today’s most telling moves.

Biggest Insider Sales

📺 Netflix $NFLX ( ▲ 0.43% ) – $23.4M from the Streaming Kingpin

• Who’s Selling? Reed Hastings (Exec COB)

• What They Sold: 25,360 shares at $921.15

• Total Value: $23.4M

• Why It Matters: Hastings is no stranger to trimming his stake, but with over 2.1M shares still in hand, this is a drop in the bucket. Still, when Netflix’s founder lightens up, it turns heads—especially as subscriber growth normalizes.

🧬 Corcept Therapeutics $CORT ( ▼ 0.11% ) – 96% Stake Slashed

• Who’s Selling? Joseph Douglas Lyon (See Remarks)

• What They Sold: 200,650 shares at $100.51

• Total Value: $20.2M

• Why It Matters: This isn’t a trim—it’s nearly a clean exit. Only 9,000 shares remain, which could raise questions about pipeline confidence or valuation ceiling in a red-hot biotech.

⚙️ Coreweave $CRWV ( ▼ 0.55% ) – Exec Suite Exits $187M

• Who’s Selling? Brian M. Venturo (Chief Strategy Officer, 10%), Jack D. Cogen (Director), Michael N. Intrator (CEO, President, 10%)

• What They Sold: Combined 3.99M shares at ~$47

• Total Value: $187.6M

• Why It Matters: A sweeping sell-off from the C-suite just ahead of a pivotal AI infrastructure ramp-up. Intrator’s 100% exit stands out. Either it's confidence in liquidity or something’s cooling under the hood.

🧪 Amylyx Pharmaceuticals $AMLX ( ▲ 2.29% ) – Co-CEOs Sync Up for $149K

• Who’s Selling? Justin B. Klee and Joshua B. Cohen (Co-CEOs)

• What They Sold: Each sold 21,490 shares around $3.47

• Total Value: $149K combined

• Why It Matters: While small compared to others, matching sales from both co-founders hint at coordinated planning—or early hedging in a volatile biotech landscape.

🛍 Macy’s $M ( ▲ 1.45% ) – C-Suite Trim Amid Turnaround

• Who’s Selling? Danielle L. Kirgan (EVP, CHRO)

• What They Sold: 4,522 shares at $12.88

• Total Value: $58K

• Why It Matters: The amount is modest, but the timing—during a high-stakes retail reinvention—suggests careful profit-taking as pressure builds across department stores.

From boardrooms to biotech labs, the sales today point to tactical trimming across industries. But while some execs are cashing in, others are doubling down.

Let’s flip the tape and break down the biggest insider buys that show where confidence is growing.

To unlock insider purchases and cluster buy alerts, upgrade to Access+.These sections show you where executives are buying, not just selling — that’s where the real edge is.

Already a paying subscriber? Sign In.

Access+ gives you full, daily access to:

• • Insider Purchase Highlights – Follow the money: execs buying their own stock
• • Cluster Buy Alerts – See when multiple insiders load up at once (a strong alpha signal)
• • Friday Deep Dive & Recap – One company, fully dissected. Who’s buying, why it matters, and what to watch next
• • Full Daily Breakdown – Premium insider trade data every weekday — no fluff, just signals that matter
• • Full Archive Access – Every edition, always unlocked
• • What’s one smart trade worth to you? Access+ is $1.63/day